New Features in SeeSAR 13.1 and infiniSee 6.1 Releases

webinar

Thu, 11 Jul 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

New Features in SeeSAR 13.1 and infiniSee 6.1 Releases

In order to succeed in research and development, state-of-the-art drug discovery requires novel methods to efficiently address existing challenges.

In this webinar, we will highlight recent major updates to both of our drug discovery platforms, SeeSAR 13.1 and infiniSee 6.1. This includes the polishing of the covalent docking utilization in the user interface: Covalent warheads are automatically detected and transformed into their target-bound form. With more adjustable parameters on hands, users can now easily fine tune their settings to achieve better results in their projects. Additional topics include the new target view control, the External Docking Mode, and many more.

As for infiniSee, we will showcase the use of the highly-anticipated R-group search in the Motif Matcher to extract expanded compounds from ultra-large Chemical Spaces. Together with augmentations to the compound handling in the Analyzer Mode, users can now perform even more sophisticated follow up with their results. Finally, use cases of the novel ad hoc libraries will be presented, allowing users to cross-screen molecules retrieved with infiniSee in its different modes.

Participants can receive a certificate of attendance, which lists the discussed topics.

Current news

Enamine's REAL Space October Update
October 8, 2024 12:23 CEST
The October update of Enamine’s REAL Space brings an impressive increase, now offering over 70 billion accessible, drug-like products, compared to 48 billion previously. With a total of 167 reactions now based on in-house knowledge and building blocks, the expansion continues to strengthen one of the largest commercially available compound collections...
Read on
category
Challenge
Winner of the Scientific Challenge Fall 2023: Jeevan Patra with Falcipain Inhibitors
September 20, 2024 10:19 CEST
We are excited to announce that Jeevan Patra is the winner of the BioSolveIT Scientific Challenge Fall 2023. Patra’s research targets Falcipain, a key enzyme in malaria, by identifying selective inhibitors from the Malaria Box, a collection of potent antimalarial candidates by the Medicines for Malaria Venture, Switzerland. With rising...
Read on
2025 Herman Skolnik Award Goes to Prof. Dr. Matthias Rarey
September 19, 2024 17:08 CEST
BioSolveIT is proud to put forth that Prof. Dr. Matthias Rarey, co-founder and a key contributor to the company’s success, shall be recognized with the 2025 Herman Skolnik Award by the American Chemical Society’s Division of Chemical Information (ACS CINF). This award honors his significant contributions to the field of...
Read on